Postpartum Psychiatric Disorders

Choosing a First-Line Treatment for Postpartum Psychosis: Why Lithium Matters

Postpartum psychosis is a psychiatric emergency. Evidence supports early use of lithium plus antipsychotics—and, when needed, ECT—to achieve remission and prevent relapse.

By |2026-04-22T09:36:34-04:00April 22nd, 2026|Postpartum Psychiatric Disorders, Postpartum Psychosis, Treatment|Comments Off on Choosing a First-Line Treatment for Postpartum Psychosis: Why Lithium Matters

Understanding Postpartum OCD and Intrusive Thoughts: Video from Dr. Marlene Freeman

In a recent video, Dr. Marlene Freeman delivers an expert commentary on postpartum OCD, highlighting research showing intrusive thoughts are common, distressing, and not linked to infant harm.

By |2026-04-20T09:47:02-04:00April 15th, 2026|OCD, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on Understanding Postpartum OCD and Intrusive Thoughts: Video from Dr. Marlene Freeman

Pharmacologic Treatment of Postpartum Depression: What Happens in the Real World?

New data reveal that while most women with postpartum depression start antidepressant treatment, many discontinue treatment early—highlighting persistent gaps in postpartum care.

By |2026-04-13T09:58:21-04:00April 14th, 2026|Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Pharmacologic Treatment of Postpartum Depression: What Happens in the Real World?

Rapid Symptom Relief in Postpartum Psychosis with Brexanolone

An open-label pilot study suggests that intravenous brexanolone may rapidly reduce psychotic, manic, and depressive symptoms in patients with postpartum psychosis, highlighting a potential new treatment option.

By |2026-04-01T06:32:10-04:00March 31st, 2026|Antidepressants, Postpartum Depression, Postpartum Psychiatric Disorders, Postpartum Psychiatric Disorders, Postpartum Psychosis, Treatment|Comments Off on Rapid Symptom Relief in Postpartum Psychosis with Brexanolone

Topiramate and Risk of Major Malformations: What Clinicians and Patients Need to Know

Topiramate exposure in early pregnancy is linked to higher rates of major malformations and more specifically to increased risk of oral clefts, with risk rising at higher doses.

By |2026-04-01T06:32:12-04:00March 26th, 2026|Medications and Pregnancy, Postpartum Psychiatric Disorders, Pregnancy Outcomes, Psychiatric Disorders During Pregnancy, Risk of Malformations|Comments Off on Topiramate and Risk of Major Malformations: What Clinicians and Patients Need to Know
Go to Top